Quanterix Corp Live Share Price Today, Share Analysis and Chart
501.4K XNAS Volume
XNAS 24 Mar, 2025 5:30 PM (EDT)
Quanterix Corp Key Metrics
Default
All financials are in USD Million and price data in USD
VIEW MORE
Low Financial Strength
Expensive Valuation
Technically Bearish
Weak Stock
These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Check Before You Buy
VIEW FULL CHECKLISTMedium rank
7Positive12Negative
36.8% Pass in checklist
Check P/E Buy Sell Zone
This stock has negative PE
Quanterix Corp Stock Price Analysis
Day Price Range | 7.2 (LTP) 7.27.5 LowHigh |
Week Price Range | 7.2 (LTP) 6.37.5 LowHigh |
Month Price Range | 7.2 (LTP) 6.38.1 LowHigh |
52 Week Price Range | 7.2 (LTP) 6.324 LowHigh |
Quanterix Corp Live Price Chart
Switch to TradingView
Fetching data ...
Revenue forecast
Hit
Quanterix Corp's Revenue was higher than average estimate 3 times in past 3 years
EPS forecast
Current EPS
Avg. Estimate
Miss
EPS is expected to reduce by 26.0% in FY25
Consensus Recommendation
4 ANALYST Recommendations
BUY
The consensus recommendation from 4 analysts for Quanterix Corp is BUY
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get Quanterix Corp Stock Analysis
Quanterix Corp stock analysis with key metrics, changes, and trends.
Quanterix Corp Metric | VALUE | CHANGE % | TREND | ANALYSIS | |
---|---|---|---|---|---|
Annual Revenue | $135.44 M | 11.8% | positive |
| |
Annual Net Profit | $38.53 M | 35.89% | negative |
| |
Price to Earning Ratio | -7.24 | - | negative |
| |
Stock Price | $7.19 | -69.18% | negative |
| |
Quarterly Revenue | $34.11 M | 9.32% | positive |
| |
Quarterly Net profit | $11.63 M | 31.94% | negative |
| |
Mutual Fund Holding | 69.22 % | 3.74% | positive |
| |
Promoter Share Holding | 9.14 % | 0.83% | positive |
| |
Institutional Holding | 91.03 % | 0% | neutral |
|
Loading data..
Quanterix Corp - Company Profile
What does Quanterix Corp do?

Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
Quanterix Corp Management structure
All Gross Remunerations are in USD
Quanterix Corp Board of directors
All Gross Remunerations are in USD